drugset / Trial / NCT01583543
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
This research study is a Phase II clinical trial to test the efficacy of Olaparib in adult participants with recurrent/metastatic Ewing's Sarcoma following failure of prior chemotherapy.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-01
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olaparib | Small molecule | 400 mg | Oral |